Argus

About:

Argus is a pharmaceutical enterprise that specializes in biological fermentation, extraction of intermediates, APIs and preparations.

Website: http://www.arguspharms.com

Top Investors: Timesbole, Qihang Touzi, Meiyuan Bencao, Hunan Boyun New Materials, Yueyangshi Benncao Shengwu

Description:

Argus is a pharmaceutical company with a concentration on biological fermentation, extraction intermediates, raw materials, and formulations. It possesses internationally advanced technology in the fields of microbial fermentation, macromolecular protein expression, and special synthesis. The business operates a large-scale microbial fermentation workshop, a line for producing drugs from raw materials, and an entire drug packaging workplace. With a robust production capacity and an extensive quality system, the company's production adheres to GMP laws and ensures product quality and delivery time.

Total Funding Amount:

33M CNY

Headquarters Location:

Changshahsien, Hunan, China

Founded Date:

2007-12-05

Contact Email:

sales(AT)arguspharms.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-09-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai